News

US FDA licenses Sanofi Pasteur's Fluzone Intradermal; fast-tracks Bayer’s regorafenib

11-05-2011

Sanofi Pasteur, the vaccines division of French drug major Sanofi (Euronext: SAN), says that the US Food…

BayerFluzoneNorth AmericaOncologyPharmaceuticalregorafenibRegulationRespiratory and PulmonarySanofi PasteurSanofi-AventisVaccines

Sanofi/Daiichi Sankyo recall hemophilus flu vaccine ActHIB due to contamination

14-03-2011

French pharma major Sanofi-Aventis’ (Euronext: SAN) Japanese vaccines subsidiary and Japan’s…

ActHIBAsia-PacificDaiichi SankyoPharmaceuticalRegulationRespiratory and PulmonarySanofi PasteurSanofi-AventisVaccines

Sanofi Pasteur pulls European MAA for Emerflu pandemic flu vaccine

07-12-2010

Sanofi Pasteur, the vaccines unit of French drug major Sanofi-Aventis (Euronext: SAN) has formally withdrawn…

EmerfluEuropePharmaceuticalRegulationRespiratory and PulmonarySanofi PasteurSanofi-AventisVaccines

Sanofi-Aventis unit returns rights for pediatric and respiratory vaccines to Crucell; invests $65 million to expand in USA

09-07-2010

Dutch biopharmaceutical company Crucell NV says it has reached agreement with Sanofi Pasteur, part of…

CrucellFinancialLicensingPharmaceuticalRespiratory and PulmonarySanofi PasteurSanofi-AventisVaccines

Back to top